Avascular tumour growth dynamics and the constraints of protein binding for drug transportation

N. Kazmi, M. A. Hossain, R. M. Phillips, M. A. Al-Mamun, R. Bass

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The potential for the use of in-silico models of disease in progression monitoring is becoming increasingly recognised, as well as its contribution to the development of complete curative processes. In this paper we report the development of a hybrid cellular automaton model to mimic the growth of avascular tumours, including the infusion of a bioreductive drug to study the effects of protein binding on drug transportation. The growth model is operated within an extracellular tumour microenvironment. An artificial Neural Network based scheme was implemented that modelled the behaviours of each cell (proliferation, quiescence, apoptosis and/or movement) based on the complex heterogeneous microenvironment; consisting of oxygen, glucose, hydrogen ions, inhibitory factors and growth factors. To validate the growth model results, we conducted experiments with multicellular tumour spheroids. These results showed good agreement with the predicted growth dynamics. The outcome of the avascular tumour growth model suggested that tumour microenvironments have a strong impact on cell behaviour. To address the problem of cellular proteins acting as resistive factors preventing efficient drug penetration, a bioreactive drug (tirapazamine) was added to the system. This allowed us to study the drug penetration through multicellular layers of tissue after its binding to cellular proteins. The results of the in vitro model suggested that the proteins reduce the toxicity of the drug, reducing its efficacy for the most severely hypoxic fractions furthest from a functional blood vessel. Finally this research provides a unique comparison of in vitro tumour growth with an intelligent in silico model to measure bioreductive drug availability inside tumour tissue through a set of experiments.

Original languageEnglish
Pages (from-to)142-152
Number of pages11
JournalJournal of Theoretical Biology
Volume313
Early online date14 Aug 2012
DOIs
Publication statusPublished - 21 Nov 2012
Externally publishedYes

Fingerprint

Tumor Growth
protein binding
Protein Binding
Tumors
Drugs
Protein
drugs
Tumor
neoplasms
Growth
Pharmaceutical Preparations
Growth Model
Neoplasms
growth models
Tumor Microenvironment
tirapazamine
Computer Simulation
Proteins
Penetration
Cellular Spheroids

Cite this

@article{951269ac69644d09ad14418ca85237bd,
title = "Avascular tumour growth dynamics and the constraints of protein binding for drug transportation",
abstract = "The potential for the use of in-silico models of disease in progression monitoring is becoming increasingly recognised, as well as its contribution to the development of complete curative processes. In this paper we report the development of a hybrid cellular automaton model to mimic the growth of avascular tumours, including the infusion of a bioreductive drug to study the effects of protein binding on drug transportation. The growth model is operated within an extracellular tumour microenvironment. An artificial Neural Network based scheme was implemented that modelled the behaviours of each cell (proliferation, quiescence, apoptosis and/or movement) based on the complex heterogeneous microenvironment; consisting of oxygen, glucose, hydrogen ions, inhibitory factors and growth factors. To validate the growth model results, we conducted experiments with multicellular tumour spheroids. These results showed good agreement with the predicted growth dynamics. The outcome of the avascular tumour growth model suggested that tumour microenvironments have a strong impact on cell behaviour. To address the problem of cellular proteins acting as resistive factors preventing efficient drug penetration, a bioreactive drug (tirapazamine) was added to the system. This allowed us to study the drug penetration through multicellular layers of tissue after its binding to cellular proteins. The results of the in vitro model suggested that the proteins reduce the toxicity of the drug, reducing its efficacy for the most severely hypoxic fractions furthest from a functional blood vessel. Finally this research provides a unique comparison of in vitro tumour growth with an intelligent in silico model to measure bioreductive drug availability inside tumour tissue through a set of experiments.",
keywords = "Avascular tumour, Microenvironments, Neural Network, Protein binding, Tirapazamine",
author = "N. Kazmi and Hossain, {M. A.} and Phillips, {R. M.} and Al-Mamun, {M. A.} and R. Bass",
year = "2012",
month = "11",
day = "21",
doi = "10.1016/j.jtbi.2012.07.026",
language = "English",
volume = "313",
pages = "142--152",
journal = "Journal of Theoretical Biology",
issn = "0022-5193",
publisher = "Academic Press Inc.",

}

Avascular tumour growth dynamics and the constraints of protein binding for drug transportation. / Kazmi, N.; Hossain, M. A.; Phillips, R. M.; Al-Mamun, M. A.; Bass, R.

In: Journal of Theoretical Biology, Vol. 313, 21.11.2012, p. 142-152.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Avascular tumour growth dynamics and the constraints of protein binding for drug transportation

AU - Kazmi, N.

AU - Hossain, M. A.

AU - Phillips, R. M.

AU - Al-Mamun, M. A.

AU - Bass, R.

PY - 2012/11/21

Y1 - 2012/11/21

N2 - The potential for the use of in-silico models of disease in progression monitoring is becoming increasingly recognised, as well as its contribution to the development of complete curative processes. In this paper we report the development of a hybrid cellular automaton model to mimic the growth of avascular tumours, including the infusion of a bioreductive drug to study the effects of protein binding on drug transportation. The growth model is operated within an extracellular tumour microenvironment. An artificial Neural Network based scheme was implemented that modelled the behaviours of each cell (proliferation, quiescence, apoptosis and/or movement) based on the complex heterogeneous microenvironment; consisting of oxygen, glucose, hydrogen ions, inhibitory factors and growth factors. To validate the growth model results, we conducted experiments with multicellular tumour spheroids. These results showed good agreement with the predicted growth dynamics. The outcome of the avascular tumour growth model suggested that tumour microenvironments have a strong impact on cell behaviour. To address the problem of cellular proteins acting as resistive factors preventing efficient drug penetration, a bioreactive drug (tirapazamine) was added to the system. This allowed us to study the drug penetration through multicellular layers of tissue after its binding to cellular proteins. The results of the in vitro model suggested that the proteins reduce the toxicity of the drug, reducing its efficacy for the most severely hypoxic fractions furthest from a functional blood vessel. Finally this research provides a unique comparison of in vitro tumour growth with an intelligent in silico model to measure bioreductive drug availability inside tumour tissue through a set of experiments.

AB - The potential for the use of in-silico models of disease in progression monitoring is becoming increasingly recognised, as well as its contribution to the development of complete curative processes. In this paper we report the development of a hybrid cellular automaton model to mimic the growth of avascular tumours, including the infusion of a bioreductive drug to study the effects of protein binding on drug transportation. The growth model is operated within an extracellular tumour microenvironment. An artificial Neural Network based scheme was implemented that modelled the behaviours of each cell (proliferation, quiescence, apoptosis and/or movement) based on the complex heterogeneous microenvironment; consisting of oxygen, glucose, hydrogen ions, inhibitory factors and growth factors. To validate the growth model results, we conducted experiments with multicellular tumour spheroids. These results showed good agreement with the predicted growth dynamics. The outcome of the avascular tumour growth model suggested that tumour microenvironments have a strong impact on cell behaviour. To address the problem of cellular proteins acting as resistive factors preventing efficient drug penetration, a bioreactive drug (tirapazamine) was added to the system. This allowed us to study the drug penetration through multicellular layers of tissue after its binding to cellular proteins. The results of the in vitro model suggested that the proteins reduce the toxicity of the drug, reducing its efficacy for the most severely hypoxic fractions furthest from a functional blood vessel. Finally this research provides a unique comparison of in vitro tumour growth with an intelligent in silico model to measure bioreductive drug availability inside tumour tissue through a set of experiments.

KW - Avascular tumour

KW - Microenvironments

KW - Neural Network

KW - Protein binding

KW - Tirapazamine

UR - http://www.scopus.com/inward/record.url?scp=84865850605&partnerID=8YFLogxK

UR - https://www.journals.elsevier.com/journal-of-theoretical-biology

U2 - 10.1016/j.jtbi.2012.07.026

DO - 10.1016/j.jtbi.2012.07.026

M3 - Article

VL - 313

SP - 142

EP - 152

JO - Journal of Theoretical Biology

JF - Journal of Theoretical Biology

SN - 0022-5193

ER -